32 research outputs found
Survivor Buddy and SciGirls: Affect, Outreach, and Questions
This paper describes the Survivor Buddy human-robot interaction project and how it was used by four middle-school girls to illustrate the scientific process for an episode of “SciGirls”, a Public Broadcast System science reality show. Survivor Buddy is a four degree of freedom robot head, with the face being a MIMO 740 multi-media touch screen monitor. It is being used to explore consistency and trust in the use of robots as social mediums, where robots serve as intermediaries between dependents (e.g., trapped survivors) and the outside world (doctors, rescuers, family members). While the SciGirl experimentation was neither statistically significant nor rigorously controlled, the experience makes three contributions. It introduces the Survivor Buddy project and social medium role, it illustrates that human-robot interaction is an appealing way to make robotics more accessible to the general public, and raises interesting questions about the existence of a minimum set of degrees of freedom for sufficient expressiveness, the relative importance of voice versus non-verbal affect, and the range and intensity of robot motions
CPT, T, and Lorentz Violation in Neutral-Meson Oscillations
Tests of CPT and Lorentz symmetry using neutral-meson oscillations are
studied within a formalism that allows for indirect CPT and T violation of
arbitrary size and is independent of phase conventions. The analysis is
particularly appropriate for studies of CPT and T violation in oscillations of
the heavy neutral mesons D, B_d, and B_s. The general Lorentz- and CPT-breaking
standard-model extension is used to derive an expression for the parameter for
CPT violation. It varies in a prescribed way with the magnitude and orientation
of the meson momentum and consequently also with sidereal time. Decay
probabilities are presented for both uncorrelated and correlated mesons, and
some implications for experiments are discussed.Comment: 11 pages, references added, accepted in Physical Review
Present and Future CP Measurements
We review theoretical and experimental results on CP violation summarizing
the discussions in the working group on CP violation at the UK phenomenology
workshop 2000 in Durham.Comment: 104 pages, Latex, to appear in Journal of Physics
Outcome of the First wwPDB/CCDC/D3R Ligand Validation Workshop.
Crystallographic studies of ligands bound to biological macromolecules (proteins and nucleic acids) represent an important source of information concerning drug-target interactions, providing atomic level insights into the physical chemistry of complex formation between macromolecules and ligands. Of the more than 115,000 entries extant in the Protein Data Bank (PDB) archive, ∼75% include at least one non-polymeric ligand. Ligand geometrical and stereochemical quality, the suitability of ligand models for in silico drug discovery and design, and the goodness-of-fit of ligand models to electron-density maps vary widely across the archive. We describe the proceedings and conclusions from the first Worldwide PDB/Cambridge Crystallographic Data Center/Drug Design Data Resource (wwPDB/CCDC/D3R) Ligand Validation Workshop held at the Research Collaboratory for Structural Bioinformatics at Rutgers University on July 30-31, 2015. Experts in protein crystallography from academe and industry came together with non-profit and for-profit software providers for crystallography and with experts in computational chemistry and data archiving to discuss and make recommendations on best practices, as framed by a series of questions central to structural studies of macromolecule-ligand complexes. What data concerning bound ligands should be archived in the PDB? How should the ligands be best represented? How should structural models of macromolecule-ligand complexes be validated? What supplementary information should accompany publications of structural studies of biological macromolecules? Consensus recommendations on best practices developed in response to each of these questions are provided, together with some details regarding implementation. Important issues addressed but not resolved at the workshop are also enumerated.The workshop was supported by funding to RCSB PDB by the National Science Foundation (DBI 1338415); PDBe by the Wellcome Trust (104948); PDBj by JST-NBDC; BMRB by the National Institute of General Medical Sciences (GM109046); D3R by the National Institute of General Medical Sciences (GM111528); registration fees from industrial participants; and tax-deductible donations to the wwPDB Foundation by the Genentech Foundation and the Bristol-Myers Squibb Foundation.This is the final version of the article. It first appeared from Cell Press via https://doi.org//10.1016/j.str.2016.02.01
Recommended from our members
Outcome of the First wwPDB/CCDC/D3R Ligand Validation Workshop
Crystallographic studies of ligands bound to biological macromolecules (proteins and nucleic acids) represent an important source of information concerning drug-target interactions, providing atomic level insights into the physical chemistry of complex formation between macromolecules and ligands. Of the more than 115,000 entries extant in the Protein Data Bank (PDB) archive, ∼75% include at least one non-polymeric ligand. Ligand geometrical and stereochemical quality, the suitability of ligand models for in silico drug discovery and design, and the goodness-of-fit of ligand models to electron-density maps vary widely across the archive. We describe the proceedings and conclusions from the first Worldwide PDB/Cambridge Crystallographic Data Center/Drug Design Data Resource (wwPDB/CCDC/D3R) Ligand Validation Workshop held at the Research Collaboratory for Structural Bioinformatics at Rutgers University on July 30–31, 2015. Experts in protein crystallography from academe and industry came together with non-profit and for-profit software providers for crystallography and with experts in computational chemistry and data archiving to discuss and make recommendations on best practices, as framed by a series of questions central to structural studies of macromolecule-ligand complexes. What data concerning bound ligands should be archived in the PDB? How should the ligands be best represented? How should structural models of macromolecule-ligand complexes be validated? What supplementary information should accompany publications of structural studies of biological macromolecules? Consensus recommendations on best practices developed in response to each of these questions are provided, together with some details regarding implementation. Important issues addressed but not resolved at the workshop are also enumerated.This is the publisher’s final pdf. The published article is copyrighted by Elsevier (Cell Press) and can be found at: http://www.cell.com/structure/hom